search

Active clinical trials for "Pulmonary Emphysema"

Results 51-60 of 198

Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction

EmphysemaChronic Obstructive Pulmonary Disease

To assess the safety and efficacy of BTVA for the treatment of patients with heterogeneous upper lobe emphysema.

Completed15 enrollment criteria

Feasibility Study of PneumRx's Lung Volume Reduction Coil (LVRC)

Emphysema

This is a multicenter single arm open label study. The primary objective is to evaluate the safety and effectiveness of the Lung Volume Reduction Coil (LVRC) for the treatment of patients with emphysema in multiple centers.

Completed11 enrollment criteria

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

Pulmonary Emphysema

Evaluate the efficacy and safety of the 10 mL BLVR System in 1 or 2 treatment sessions (8 subsegments, 4 in each lung) in patients with advanced upper lobe predominant emphysema.

Completed16 enrollment criteria

Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive...

Chronic Obstructive Pulmonary DiseaseBronchitis1 more

To evaluate the long-term safety and monitor the long-term efficacy of arformoterol over a period of 6 months in subjects with chronic obstructive pulmonary disease (COPD).

Completed11 enrollment criteria

Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease

Emphysema

The purpose of this study is to determine if osteopathic manipulative treatment (OMT) is effective for persons with emphysema as a component of their chronic obstructive pulmonary disease.

Completed0 enrollment criteria

Losartan Effects on Emphysema Progression

Emphysema

A randomized, parallel, placebo controlled trial to evaluate the effect of 100mg/day losartan on the progression of emphysema as measured by quantitative HRCT compared to placebo .

Completed26 enrollment criteria

Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study

Emphysema

This study is designed to demonstrate safety and efficacy in patients with severe upper lobe predominant emphysema. For validity of the study, the results will be compared to patients that receive optimal medical therapy.

Completed13 enrollment criteria

Prostaglandin Inhibition for Emphysema

Emphysema

The Prostaglandin Inhibition for Emphysema (PIE) study will determine if a currently available therapy, ibuprofen 600 mg three times daily, can block PGE production in the lower respiratory tract and if this results in improvement in measures of lung repair function.

Completed15 enrollment criteria

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant...

EmphysemaChronic Obstructive Pulmonary Disease (COPD)6 more

The purpose of this research study is to learn about the safety of transplanting lungs obtained from non-heart-beating donors (NHBDs) that have been ventilated (attached to a breathing machine or ventilator to deliver oxygen) and perfused with a lung perfusion solution (Steen solution™, made by Vitrolife). This ventilation and perfusion will be done outside the body (ex-vivo) in a modified cardiopulmonary bypass circuit (the kind of device used routinely during most heart surgeries). The purpose of performing ex-vivo perfusion and ventilation is to learn how well the lungs work, and whether they are likely safe to transplant.

Completed7 enrollment criteria

Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function

Emphysema

EMPROVE is a multicenter, prospective, randomized, controlled study designed to evaluate the safety and long-term effectiveness of the Spiration Valve System in patients with emphysema. Patients appropriate for the EMPROVE study are those who are currently on medical treatment but still symptomatic. EMPROVE also accepts α-1 antitrypsin deficiency patients.

Completed18 enrollment criteria
1...567...20

Need Help? Contact our team!


We'll reach out to this number within 24 hrs